Could It Happen Here? India s Dire COVID Situation Likely to Worsen medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Close
Pictured, from left, are Dr. Timothy B. Daniel, Dr. Frederick D. Johnson Jr., and Dr. Craig A. Yokley.
Colquitt Regional Medical Center
Staff Reports
2 hrs ago
Pictured, from left, are Dr. Timothy B. Daniel, Dr. Frederick D. Johnson Jr., and Dr. Craig A. Yokley. Colquitt Regional Medical Center
MOULTRIE, Ga. â Colquitt Regional Medical Center recently welcomed three new physicians to its medical staff. Dr. Timothy B. Daniel, Dr. Frederick D. Johnson, Jr., and Dr. Craig A. Yokley will be leading the hospitalâs new vascular interventional service line.
On April 1, Daniel, Johnson, and Yokley began seeing patients at Colquitt Regional. They will also continue to see patients at their practice, Vascular Interventional of Thomasville, Associates (VITA), in Thomasville, Georgia.
E-Mail
BOSTON - At the start of the COVID-19 pandemic, very little was known about SARS-CoV-2, the virus that causes COVID-19. Over the past year, more evidence has become available on how the virus is transmitted, who is at the greatest risk and best practices to prevent exposure. Yet questions still remain about how the virus impacts the health of pregnant women and newborns.
In a new study published in
JAMA Network Open, physician-researchers from Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women s Hospital, Boston Children s Hospital and Massachusetts General Hospital reveal that, while mother-to-newborn transmission of the virus is rare, newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks as a result of worsening maternal COVID-19 illness.
First-of-its-Kind Study Found Infants of Socially Vulnerable Mothers were at Highest Risk of COVID-19 Infection
BOSTON – At the start of the COVID-19 pandemic, very little was known about SARS-CoV-2, the virus that causes COVID-19. Over the past year, more evidence has become available on how the virus is transmitted, who is at the greatest risk and best practices to prevent exposure. Yet questions still remain about how the virus impacts the health of pregnant women and newborns.
In a new study published in JAMA Network Open, physician-researchers from Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women’s Hospital, Boston Children’s Hospital and Massachusetts General Hospital reveal that, while mother-to-newborn transmission of the virus is rare, newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks as a result of worsening maternal COVID-19 illness.
April 19, 2021
Selecting a post-PCI antiplatelet regimen based on platelet function or genetic testing seems to improve both efficacy and safety, according to a new meta-analysis. Its authors say the results support the next frontier of personalized medicine despite the lack of randomized trial evidence.
Prior studies, like last year’s TAILOR-PCI, have failed to establish the superiority of a guided antiplatelet strategy over standard therapy, but proponents say no trial so far has been accurately powered to do so.
This 20,000-patient meta-analysis, which combined the TAILOR-PCI, POPular Genetics, TROPICAL-ACS, and PHARMCLO trials, among others, was designed to overcome prior research pitfalls, lead author Mattia Galli, MD (Catholic University of the Sacred Heart, Rome, Italy, and University of Florida College of Medicine, Jacksonville), told TCTMD.